DV
Dividend Vision

ADPT — Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation (ADPT)

Total return is -38.6% over the past 7.1 years, 233.6 points behind SPY at 195.0%. Its deepest 1-year drawdown was 39.3%.

ADPT is a healthcare equity stock that focuses on adaptive biotechnologies. The fund does not currently distribute dividends and therefore has no yield profile or distribution frequency. This holding appeals primarily to growth-oriented investors seeking exposure to biotechnology innovation rather than those focused on income generation.

ADPT key facts

Asset type
Stock
Asset class
Equity
Inception date
06/27/2019
Distribution frequency
None
Last close
$24.74
Market cap
$3,935,134,976
Average volume
1743300.0
Beta
2.088
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.40